Shreyas Joshi

Also affiliated with Emory University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial”.

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

The Lancet(2021)10.1016/s0140-6736(21)00581-x

N/A

6.4DataRank · unranked

186 citations

Eduard Schreibmann, Subir Goyal, Raghuveer Halkar, Bruce Hershatter, Peter J. Rossi +14 more

Differentiation fate of a stem-like CD4 T cell controls immunity to cancer

Nature(2024)10.1038/s41586-024-08076-7

N/A

1.1DataRank · unranked

57 citations

Nataliya Prokhnevska, Ewelina Sobierajska, Petra Gregorova, Christopher B. Medina, Rajesh M. Valanparambil +9 more

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851

N/A

0.515DataRank · unranked

30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation

Cancer(2024)10.1002/cncr.35465

N/A

0.422DataRank · unranked

6 citations

Katherine Case, Derrik Gratz, Kathryn L. Pellegrini, Elizabeth Beagle, Thomas M. Schneider +12 more

[18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial

European Urology(2025)10.1016/j.eururo.2025.12.003

N/A

0.312DataRank · unranked

7 citations

Vishal R. Dhere, Subir Goyal, Eduard Schreibmann, Pretesh Patel, Bruce Hershatter +16 more

Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.563

N/A

0.104DataRank · unranked

1 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron +12 more

Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.738

N/A

0.104DataRank · unranked

1 citations

Yuan Liu, Dylan J. Martini, Julie M. Shabto, Elise Hitron, Greta Russler +11 more

Utilization, health care expenditures, and patient costs of definitive treatment modalities for localized prostate cancer in the United States

Cancer(2025)10.1002/cncr.35795

N/A

0DataRank · unranked

6 citations

Dattatraya Patil, Pretesh Patel, Ashesh B. Jani, Bruce Hershatter, Vishal R. Dhere +7 more

Bladder preserving chemoradiotherapy compared to surgery for variants of urothelial carcinoma and other tumors types involving the bladder: An analysis of the National Cancer Database

Clinical and Translational Radiation Oncology(2020)10.1016/j.ctro.2020.11.002

N/A

0DataRank · unranked

14 citations

Jim Zhong, Yuan Liu, Chao Zhang, Adeboye O. Osunkoya, Shreyas Joshi +7 more

Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma 3215

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1039

N/A

0DataRank · unranked

0 citations

BaoHan T. Vo, Mehmet Asım Bilen, Yuan Liu, Amir H. Davarpanah, Bassel Nazha +16 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922

N/A

0DataRank · unranked

32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more

Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2021.01.002

N/A

0DataRank · unranked

5 citations

Yuan Liu, Theresa Gillespie, Adeboye O. Osunkoya, Bradley Curtis Carthon, Mehmet Asım Bilen +8 more

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

Immunity(2022)10.1016/j.immuni.2022.12.002

N/A

0DataRank · unranked

350 citations

Maria A. Cardenas, Rajesh M. Valanparambil, Ewelina Sobierajska, Benjamin G. Barwick, Caroline S. Jansen +13 more

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154

N/A

0DataRank · unranked

12 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha +13 more

Impact of 18F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy

Clinical Nuclear Medicine(2023)10.1097/rlu.0000000000004590

N/A

0DataRank · unranked

10 citations

Charles Marcus, David M. Schuster, Subir Goyal, Omotayo A. Adediran, Vishal R. Dhere +12 more

Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes

American Journal of Clinical Pathology(2024)10.1093/ajcp/aqae161

N/A

0DataRank · unranked

5 citations

Dylan J. Martini, Melad Dababneh, Samuel Bidot, Bassel Nazha, Jacqueline T. Brown +7 more